Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-310
Closed -$11K 738
2016
Q1
$11K Buy
310
+110
+55% +$3.84K 0.01% 307
2015
Q4
$8K Hold
200
0.01% 251
2015
Q3
$8K Hold
200
0.01% 254
2015
Q2
$8K Hold
200
0.01% 240
2015
Q1
$7K Hold
200
﹤0.01% 250
2014
Q4
$5K Hold
200
﹤0.01% 265
2014
Q3
$5K Hold
200
﹤0.01% 257
2014
Q2
$5K Hold
200
﹤0.01% 271
2014
Q1
$4K Buy
+200
New +$4.32K ﹤0.01% 266

Other funds holding HOLX

Winfield Associates's HOLX Position: Q2 2016 in Review

Winfield Associates sold out of Hologic (HOLX) in Q2 2016, closing a stake of 310 shares — an estimated $11K sold.

Winfield Associates first reported a position in HOLX in Q1 2014 and held it in 9 quarters. The position peaked at $11K in Q1 2016. 459 funds tracked by Wall St. Rank hold HOLX as of Q2 2016.

  • Winfield Associates reported no remaining Hologic position as of Q2 2016 after selling out during the quarter.
  • Winfield Associates sold 310 Hologic shares in Q2 2016, an estimated $11K.
  • Winfield Associates first reported a position in Hologic in Q1 2014 and held it in 9 quarters.
  • Winfield Associates's Hologic position peaked at $11K in Q1 2016.
  • 459 funds tracked by Wall St. Rank held Hologic as of Q2 2016.

Based on Winfield Associates's 13F filing for Q2 2016, filed 15 Aug 2016.